News

The previously disclosed September 8, 2015 PDUFA date has been extended by the standard extension period of three months. In response to a recent request from the FDA,

The procedure, in which all five of the patient’s brain metastases were treated, took less than 20 minutes, including setup time using the Brainlab technology. Using the traditional

The product will be marketed by Alvogen in three strengths (4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours) with Alvogen being the first filer for the

IGI Laboratories president and CEO Jason Grenfell-Gardner said: "We believe our current pipeline of twenty-nine submissions, exclusive of our four partnered submissions, pending approval by the FDA now

GBR 830 is an antagonist of OX40, a costimulatory receptor expressed on T cells mediating T cell activation and survival. GBR 830 was found to be well tolerated

The 19,000m2 warehouse will have a capacity of around 17,000 pallets and handle all inbound raw materials meant for Novo Nordisk’s production in Denmark. Currently, Novo Nordisk’s facility

The collaboration will focus on Redx’s existing pan-RAF inhibitor program, which is focused on colorectal cancer, the fourth most common cancer and the second most common cause of

This is an effort by Pfizer, which manufactures arthritis pill Celebrex, Prevnar pneumococcal vaccines and the fibromyalgia drug Lyrica, to gain a leading position in the global market

The strategic alliance is aimed at developing new cancer immunotherapies based on Cellectis’ allogeneic chimeric antigen receptor (CAR) platform. MD Anderson Cancer Center’s leukemia and myeloma teams will